| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.007 |